Follow
Meral Beksac
Meral Beksac
Verified email at medicine.ankara.edu.tr
Title
Cited by
Cited by
Year
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
48732014
International uniform response criteria for multiple myeloma
BGM Durie, JL Harousseau, JS Miguel, J Blade, B Barlogie, K Anderson, ...
Leukemia 20 (9), 1467-1473, 2006
34242006
Daratumumab, bortezomib, and dexamethasone for multiple myeloma
A Palumbo, A Chanan-Khan, K Weisel, AK Nooka, T Masszi, M Beksac, ...
New England Journal of Medicine 375 (8), 754-766, 2016
16422016
Elotuzumab therapy for relapsed or refractory multiple myeloma
S Lonial, M Dimopoulos, A Palumbo, D White, S Grosicki, I Spicka, ...
New England Journal of Medicine 373 (7), 621-631, 2015
14952015
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
A Palumbo, R Hajek, M Delforge, M Kropff, MT Petrucci, J Catalano, ...
New England Journal of Medicine 366 (19), 1759-1769, 2012
9062012
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a …
JF San-Miguel, VTM Hungria, SS Yoon, M Beksac, MA Dimopoulos, ...
The lancet oncology 15 (11), 1195-1206, 2014
8872014
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
AC Rawstron, A Orfao, M Beksac, L Bezdickova, R Brooimans, H Bumbea, ...
haematologica 93 (3), 431-438, 2008
6542008
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a …
M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ...
The Lancet 394 (10214), 2096-2107, 2019
610*2019
The shaping of modern human immune systems by multiregional admixture with archaic humans
L Abi-Rached, MJ Jobin, S Kulkarni, A McWhinnie, K Dalva, L Gragert, ...
Science 334 (6052), 89-94, 2011
5912011
Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
M Dimopoulos, R Kyle, JP Fermand, SV Rajkumar, J San Miguel, ...
Blood, The Journal of the American Society of Hematology 117 (18), 4701-4705, 2011
5272011
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
A Palumbo, S Bringhen, H Ludwig, MA Dimopoulos, J Bladé, MV Mateos, ...
Blood, The Journal of the American Society of Hematology 118 (17), 4519-4529, 2011
4602011
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
4242016
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
M Dimopoulos, E Terpos, RL Comenzo, P Tosi, M Beksac, O Sezer, ...
Leukemia 23 (9), 1545-1556, 2009
4012009
European Myeloma Network guidelines for the management of multiple myeloma-related complications
E Terpos, M Kleber, M Engelhardt, S Zweegman, F Gay, E Kastritis, ...
haematologica 100 (10), 1254, 2015
3962015
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label …
PG Richardson, A Oriol, M Beksac, AM Liberati, M Galli, F Schjesvold, ...
The Lancet Oncology 20 (6), 781-794, 2019
3472019
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
PM Fayers, A Palumbo, C Hulin, A Waage, P Wijermans, M Beksaç, ...
Blood, The Journal of the American Society of Hematology 118 (5), 1239-1247, 2011
3462011
Daratumumab-based treatment for immunoglobulin light-chain amyloidosis
E Kastritis, G Palladini, MC Minnema, AD Wechalekar, A Jaccard, HC Lee, ...
New England Journal of Medicine 385 (1), 46-58, 2021
3322021
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and …
M Cavo, F Gay, M Beksac, L Pantani, MT Petrucci, MA Dimopoulos, ...
The Lancet Haematology 7 (6), e456-e468, 2020
3172020
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
SK Kumar, MA Dimopoulos, E Kastritis, E Terpos, H Nahi, H Goldschmidt, ...
Leukemia 31 (11), 2443-2448, 2017
3162017
Management of treatment-emergent peripheral neuropathy in multiple myeloma
PG Richardson, M Delforge, M Beksaç, P Wen, JL Jongen, O Sezer, ...
Leukemia 26 (4), 595-608, 2012
3072012
The system can't perform the operation now. Try again later.
Articles 1–20